Monopoly Rights for High-Volume Gasotyle Plus

Dominate the Bloating & Digestive Discomfort Market

Gasotyle Plus Edge: Dual-Action Enzyme & Anti-Foaming Relief

Secure Your Competition-Free Gastro Territory Today

Minimal Investment, Maximum Marketing Support & Stock Availability
Launch Your High-Demand Digestive Enzyme Business Now!

Home/Products /alpha-galactosidase-150-mg-simethicone-25-mg-tablet

Gasotyle Plus Tablet

Composition : Alpha Galactosidase (150 mg) + Simethicone (25 mg)

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Gasotyle Plus Tablet is a high-volume, general-use product that promises guaranteed prescription flow and impressive returns in the Gastrology segment.

This tablet offers a powerful dual-action formula:

  • Alpha Galactosidase: This enzyme breaks down complex indigestible carbohydrates (oligosaccharides) in the small intestine, preventing fermentation and reducing gas formation at the source.

  • Simethicone: This antifoaming agent works locally to break down existing gas bubbles, aiding in their rapid and comfortable expulsion (burping/flatus).

Why Gasotyle Plus is Your Fastest-Moving Franchise Product:

  • Mass Market Appeal: Directly addresses the most common gastro complaints (bloating, gas) related to modern diet and lifestyle, ensuring universal and consistent prescription demand.

  • Unique Combination Advantage: The dual mechanism offers more comprehensive relief than single-molecule products, driving higher prescription preference from GPs and Specialists.

  • High Inventory Turnover: As a common digestive aid, it boasts one of the fastest sales cycles in the pharma market, guaranteeing quick capital rotation and superior profit realization.

Secure your exclusive Gasotyle Plus territory now! 

Read More

About the Product

Gasotyle Plus Tablet is a high-volume, general-use product that promises guaranteed prescription flow and impressive returns in the Gastrology segment.

This tablet offers a powerful dual-action formula:

  • Alpha Galactosidase: This enzyme breaks down complex indigestible carbohydrates (oligosaccharides) in the small intestine, preventing fermentation and reducing gas formation at the source.

  • Simethicone: This antifoaming agent works locally to break down existing gas bubbles, aiding in their rapid and comfortable expulsion (burping/flatus).

Why Gasotyle Plus is Your Fastest-Moving Franchise Product:

  • Mass Market Appeal: Directly addresses the most common gastro complaints (bloating, gas) related to modern diet and lifestyle, ensuring universal and consistent prescription demand.

  • Unique Combination Advantage: The dual mechanism offers more comprehensive relief than single-molecule products, driving higher prescription preference from GPs and Specialists.

  • High Inventory Turnover: As a common digestive aid, it boasts one of the fastest sales cycles in the pharma market, guaranteeing quick capital rotation and superior profit realization.

Secure your exclusive Gasotyle Plus territory now! 

This combination is generally well tolerated. Rarely, mild side effects such as nausea, mild diarrhea, or stomach upset may occur. If persistent discomfort or allergic reactions develop, discontinue use and consult a healthcare professional.

Gasotyle Plus Tablet is indicated for the relief of flatulence, bloating, and discomfort due to indigestion or excessive gas. It is especially useful for individuals experiencing digestive issues after consuming gas-producing foods, helping restore comfort and ease.

Take Gasotyle Plus Tablet as directed, usually with meals or immediately after eating gas-producing foods. Do not exceed the recommended dose. Individuals with known allergies to any component should avoid this medication.

Store Gasotyle Plus Tablet in a cool, dry place below 25°C, protected from moisture and sunlight. Keep out of reach of children and do not use after the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation